dc.contributor.author | Freeman, JA | |
dc.contributor.author | Hendrie, W | |
dc.contributor.author | Creanor, S | |
dc.contributor.author | Jarrett, L | |
dc.contributor.author | Barton, A | |
dc.contributor.author | Green, C | |
dc.contributor.author | Marsden, J | |
dc.contributor.author | Rogers, E | |
dc.contributor.author | Zajicek, J | |
dc.date.accessioned | 2016-05-06T13:09:13Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Background: Multiple sclerosis (MS) is an incurable, unpredictable but typically progressive neurological condition.
It is the most common cause of neurological disability in young adults. Within 15 years of diagnosis, approximately
50 % of affected people are unable to walk unaided, and over time an estimated 25 % depend on a wheelchair.
Typically, people with such limited mobility are excluded from clinical trials. Severely impaired people with MS
spend much of their day sitting, often with limited ability to change position. In response, secondary complications
can occur including: muscle wasting, pain, reduced skin integrity, spasms, limb stiffness, constipation, and
associated psychosocial problems such as depression and lowered self-esteem. Effective self-management
strategies, which can be implemented relatively easily and cheaply within people’s homes, are needed to improve
or maintain mobility and reduce sedentary behaviour. However this is challenging, particularly in the latter stages of
disease. Regular supported standing using standing frames is one potential option.
Methods/Design: SUMS is a pragmatic multi-centre randomised controlled trial evaluating use of Oswestry
standing frames with blinded outcome assessment and full economic evaluation. Participants will be randomly
allocated (1:1) to either a home-based, self-management standing programme (with advice and support) along
with their usual care or to usual care alone. Those in the intervention group will be asked to stand for a minimum
of 30 min three times weekly over 20 weeks. Each participant will be followed-up at 20 and 36 weeks post baseline.
The primary clinical outcome is motor function, assessed using the Amended Motor Club Assessment. The primary
economic endpoint is quality-adjusted life years. The secondary outcomes include measures of explanatory physical
impairments, key clinical outcomes, and health–related quality of life. An embedded qualitative component will
explore participant’s and carer’s experiences of the standing programme. Discussion: This is the first large scale multi-centre trial to assess the clinical and cost effectiveness of a home
based standing frame programme for people who are severely impaired by MS. If demonstrated to be effective and
cost-effective, we will use this evidence to develop recommendations for a health service delivery model which
could be implemented across the United Kingdom. | en_GB |
dc.description.sponsorship | This study is funded by the NIHR Research for Patient Benefit Programme
(PB-PG-1013-32047), United Kingdom. This article presents independent
research. The views expressed are those of the authors and not necessarily
those of the NHS, the NIHR or the Department of Health. Sponsor of this
clinical study is the Plymouth Hospitals NHS Trust, Devon, England, UK. | en_GB |
dc.identifier.citation | Vol. 16: 62 | en_GB |
dc.identifier.doi | 10.1186/s12883-016-0581-8 | |
dc.identifier.uri | http://hdl.handle.net/10871/21413 | |
dc.language.iso | en | en_GB |
dc.publisher | BioMed Central | en_GB |
dc.rights | This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated | en_GB |
dc.subject | Progressive Multiple Sclerosis | en_GB |
dc.subject | Standing | en_GB |
dc.subject | Standing frame | en_GB |
dc.subject | Physiotherapy | en_GB |
dc.subject | Self-management | en_GB |
dc.subject | Cost effectiveness | en_GB |
dc.subject | Mobility | en_GB |
dc.title | Standing up in Multiple Sclerosis (SUMS): Protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis. | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2016-05-06T13:09:13Z | |
dc.identifier.issn | 1471-2377 | |
dc.description | This is the final version of the article. Available from the publisher via the DOI in this record. | en_GB |
dc.identifier.journal | BMC Neurology | en_GB |